Partner with us
← Pipeline

KL-P1 · Immunology · with Aldermoor

Autoimmune disease

A program with our partner Aldermoor. Keyline designs the binders; Aldermoor leads development.

Target
Not disclosed
Type
De novo designed miniprotein
Stage
Discovery
Progress

The partnership

Keyline designs and tests the binders. Aldermoor takes the best design forward into development and trials.

News and papers on KL-P1

Press release

Keyline and Aldermoor start a partnership in autoimmune disease

Keyline will design binders for one target chosen by Aldermoor.

Work with us on a target.

We partner with drug companies on targets that are hard for their current tools.

Partner with usAll programs